Stimulation of Epstein-Barr virus-infected human B cell growth by physiological concentrations of 4-hydroxynonenal

Cell Biochemistry and Function

Volumn 24, Issue 2, 2006, Pages 147-152

  Ranjan, Dinesh ^a,b   Chen, Changguo ^a   Johnston, Thomas D ^a   Jeon, Hoonbae ^a   Ibrahim, Mohamed ^a   Drake, Jennifer ^b   Butterfield, D Allan ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

4 Hydroxynonenal; Cyclosporin A; Epstein Barr virus; Human B cells; Lipid peroxidation; Oxidative stress; Post transplant lymphoproliferative disorder (PTLD)

Indexed keywords

4 HYDROXYNONENAL; CYCLOSPORIN A; LATENT MEMBRANE PROTEIN 1; THYMIDINE;

ARTICLE; B LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPSTEIN BARR VIRUS; EXPERIMENTAL MODEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LIPID PEROXIDATION; LYMPHOPROLIFERATIVE DISEASE; ONCOGENE; OXIDATIVE STRESS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; SLOT BLOT HYBRIDIZATION; VIRUS ACTIVATION; VIRUS INFECTION;

ALDEHYDES; B-LYMPHOCYTES; CYCLOSPORINE; EPSTEIN-BARR VIRUS INFECTIONS; LIPID PEROXIDATION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 33645308821     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1201     Document Type: Article

References (33)

1. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
2. Zollner H, Schaur RJ, Esterbauer H. Biological activities of 4-hydroxynonenal. In Oxidative Stress: Oxidants and Antioxidants, Sies H (ed.). Academic Press: London and New York, 1991; 337-355.
3. Fazio VM, Rinaldi M, Ciafre S, Barrera G, Farace MG. Control of neoplastic cell proliferation and differentiation by restoration of 4-hydroxynonenal physiological concentrations. Mol Aspects Med 1993; 14: 217-228.
4. Semlitsch T, Tillian HM, Zarkovic N, et al. Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes. Anticancer Res 2002; 22: 1689-1697.
5. Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 1993; 11: 279-286.
6. Chen C, Johnston TD, Reddy KS, Merrick JC, Mastrangelo M, Ranjan D. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells. J Surg Res 2001; 100: 166-170.
7. Ranjan D, Siquijor A, Johnston TD, Wu G, Nagabhuskahn M. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am Surg 1998; 64: 47-51.
8. Caputo JL, Thompson A, McClintock P, Reid YA, Hay RJ. An effective method for establishing human lymphoblastic cell lines using Epstein-Barr virus. J Tissue Cult Methods 1991; 13: 39-44.
9. Lauderback CM, Hackett JM, Huang FF, et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 2001; 78: 413-416.
10. 2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression. J Surg Res 2003; 113: 228-233.
11. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
12. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996; 93: 2696-2701.
13. Travo P, Barrett G, Burnstock G. Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels 1980; 17: 110-116.
14. Fazio VM, Barrera G, Martinotti S, et al. 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. Cancer Res 1992; 52: 4866-4871.
15. Barrera G, Pizzimenti S, Muraca R, et al. Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. Free Radic Biol Med 1996; 20: 455-462.
16. Malecki A, Garrido R, Mattson MP, Hennig B, Toborek M. 4-Hydroxynonenal induces oxidative stress and death of cultured spinal cord neurons. J Neurochem 2000; 74: 2278-2287.
17. Poot M, Esterbauer H, Rabinovitch PS, Hoehn H. Disturbance of cell proliferation by two model compounds of lipid peroxidation contradicts causative role in proliferative senescence. J Cell Physiol 1988; 137: 421-429.
18. Krokan H, Grafstrom RC, Sundqvist K, Esterbauer H, Harris CC. Cytotoxicity, thiol depletion and inhibition of O6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. Carcinogenesis 1985; 6: 1755-1759.
19. Kalinich JF, Ramakrishnan R, McClain DE, Ramakrishnan N. 4-Hydroxynonenal, an end-product of lipid peroxidation, induces apoptosis in human leukemic T- and B-cell lines. Free Radic Res 2000; 33: 349-358.
20. Kakishita H, Hattori Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sci 2001; 69: 689-697.
21. Ruef J, Rao GN, Li F, et al. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation 1998; 97: 1071-1078.
22. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991; 266: 8604-8608.
23. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243: 393-396.
24. Calonghi N, Boga C, Cappadone C, et al. Cytotoxic and cytostatic effects induced by 4-hydroxynonenal in human osteosarcoma cells. Biochem Biophys Res Commun 2002; 293: 1502-1507.
25. Roberts ML, Cooper NR. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 1998; 240: 93-99.
26. Fenton M, Sinclair AJ. Divergent requirements for the MAPK(ERK) signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters. J Virol 1999; 73: 8913-8916.
27. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993; 90: 9150-9154.
28. Kilger E, Kieser A, Baumann M, Hammerschmidt W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 1998; 17: 1700-1709.
29. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840.
30. Brodeur SR, Cheng G, Baltimore D, Thorley-Lawson DA. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J Biol Chem 1997; 272: 19777-19784.
31. Devergne O, Hatzivassiliou E, Izumi KM, et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol 1996; 16: 7098-7108.
32. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 1997; 16: 6478-6485.
33. Wan J, Sun L, Mendoza JW, et al. Elucidation of the c-Jun N-terminal kinase pathway mediated by Epstein-Barr virus-encoded latent membrane protein 1. Mol Cell Biol 2004; 24: 192-199.